Skip to main content

Endoscopic Ultrasound Shear Wave Elastography Study

Recruiting · NCT06592820

Conditions: MASLD, MASH, Fibrosis, Liver, Chronic Liver Disease

At a glance

Research payments reported, 2025
$37,895
U.S. investigators named
3
Sites paid
3
Planned or actual enrollment
300

About the trial

Sponsor
Olympus Corporation of the Americas
Tested
Endoscopic Ultrasound Shear Wave Elastography (EUS) and Attenuation Imaging (device), FibroScan (device), Liver biopsy (device)
Dates
Started 2025-09-03; completion 2027-03-28
Results posted
Not yet

This study shall be a prospective, multicenter, single arm, consecutive, interventional study conducted in a post-market setting using commercially available devices. Consecutive, eligible patients with clinical suspicion of MASLD or MASH reporting for an endoscopic ultrasound and liver biopsy for evaluation of fibrosis will be enrolled. EUS Shear Wave Elastography and Attenuation Imaging technologies will be compared to liver biopsy and FibroScan results and other non-invasive fibrosis screening modalities . The data collected during this study will be evaluated in accordance with the procedures set forth in the protocol. The main question\[s\] it aims to answer are: * Establish optimal …

From ClinicalTrials.gov, last updated 2025-09-15. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Gyrus Acmi, Inc. reported $37,895 in research payments for this study in 2025 (4 payments).

Products named: Diagnostic Ultrasound System

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.